Reperfusion-induced ventricular fibrillation. Modification by pharmacological agents

Area of Science:

• Cardiovascular Pharmacology
• Cardiac Electrophysiology
• Antiarrhythmic Drug Research

Background:

• Reperfusion-induced ventricular fibrillation is a critical complication following transient coronary artery occlusion.
• Understanding the efficacy of different antiarrhythmic drug classes in preventing this event is crucial for therapeutic development.
• Epinephrine was used to provide exogenous catecholamine support in the experimental model.

Purpose of the Study:

• To evaluate the effectiveness of major antiarrhythmic agent groups in preventing reperfusion-induced ventricular fibrillation.
• To compare the protective effects of fast sodium channel inhibitors, beta-adrenergic blockers, and slow calcium channel antagonists.

Main Methods:

• Isolated working rat heart preparation subjected to transient coronary artery occlusion.
• Perfusion with Krebs-Henseleit medium containing epinephrine.
• Assessment of antiarrhythmic agents: lignocaine, prenylamine, oxprenolol, timolol, metoprolol, acebutolol, and nifedipine at specified concentrations.

Main Results:

• Control hearts showed over 90% incidence of ventricular fibrillation upon reperfusion.
• Prenylamine and lignocaine (fast sodium channel inhibitors) significantly reduced fibrillation incidence (0% and 33-83% respectively).
• Beta-blockers (timolol, oxprenolol) and nifedipine (calcium channel antagonist) offered no significant protection; metoprolol and acebutolol showed partial protection.

Conclusions:

• Inhibition of the fast inward sodium channel is the most effective strategy against reperfusion-induced ventricular fibrillation.
• Beta-blockade and slow calcium channel inhibition do not provide significant protection in this model.
• Partial protection by metoprolol and acebutolol may stem from membrane-stabilizing properties rather than beta-blockade.